Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

The gut microbiome and atherosclerosis: current knowledge and clinical potential.

Ahmad A, Dwivedi G, O'Gara F, Caparros-Martin J, Ward N.

Am J Physiol Heart Circ Physiol. 2019 Aug 30. doi: 10.1152/ajpheart.00376.2019. [Epub ahead of print]

PMID:
31469291
2.

The Microbiome of an Active Meat Curing Brine.

Woods DF, Kozak IM, Flynn S, O'Gara F.

Front Microbiol. 2019 Jan 11;9:3346. doi: 10.3389/fmicb.2018.03346. eCollection 2018.

3.

Genome Sequence of Paracoccus sp. JM45, a Bacterial Strain Isolated from a Marine Sponge with a Dual Quorum Sensing Inhibition Activity.

Gutiérrez-Barranquero JA, Parages ML, Dobson ADW, Reen FJ, O'Gara F.

Microbiol Resour Announc. 2019 Jan 10;8(2). pii: e01496-18. doi: 10.1128/MRA.01496-18. eCollection 2019 Jan.

4.

Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet.

Tan S, Caparros-Martin JA, Matthews VB, Koch H, O'Gara F, Croft KD, Ward NC.

Sci Rep. 2018 Jul 4;8(1):10100. doi: 10.1038/s41598-018-28521-8.

5.

Harnessing Marine Biocatalytic Reservoirs for Green Chemistry Applications through Metagenomic Technologies.

Castilla IA, Woods DF, Reen FJ, O'Gara F.

Mar Drugs. 2018 Jul 4;16(7). pii: E227. doi: 10.3390/md16070227. Review.

6.

The expanding horizon of alkyl quinolone signalling and communication in polycellular interactomes.

Reen FJ, McGlacken GP, O'Gara F.

FEMS Microbiol Lett. 2018 May 1;365(9). doi: 10.1093/femsle/fny076. Review.

PMID:
29718276
7.

Rethinking the bile acid/gut microbiome axis in cancer.

Phelan JP, Reen FJ, Caparros-Martin JA, O'Connor R, O'Gara F.

Oncotarget. 2017 Dec 1;8(70):115736-115747. doi: 10.18632/oncotarget.22803. eCollection 2017 Dec 29. Review.

8.

Rapid Electrochemical Detection of Pseudomonas aeruginosa Signaling Molecules by Boron-Doped Diamond Electrode.

Buzid A, Luong JHT, Reen FJ, O'Gara F, Glennon JD, McGlacken GP.

Methods Mol Biol. 2018;1673:107-116. doi: 10.1007/978-1-4939-7309-5_9.

PMID:
29130168
9.

Disruption of N-acyl-homoserine lactone-specific signalling and virulence in clinical pathogens by marine sponge bacteria.

Gutiérrez-Barranquero JA, Reen FJ, Parages ML, McCarthy R, Dobson ADW, O'Gara F.

Microb Biotechnol. 2019 Sep;12(5):1049-1063. doi: 10.1111/1751-7915.12867. Epub 2017 Nov 3.

10.

Analogues of Pseudomonas aeruginosa signalling molecules to tackle infections.

Ó Muimhneacháin E, Reen FJ, O'Gara F, McGlacken GP.

Org Biomol Chem. 2018 Jan 3;16(2):169-179. doi: 10.1039/c7ob02395b. Review.

PMID:
29095463
11.

Identification of Secondary Metabolite Gene Clusters in the Pseudovibrio Genus Reveals Encouraging Biosynthetic Potential toward the Production of Novel Bioactive Compounds.

Naughton LM, Romano S, O'Gara F, Dobson ADW.

Front Microbiol. 2017 Aug 18;8:1494. doi: 10.3389/fmicb.2017.01494. eCollection 2017.

12.

Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.

Caparrós-Martín JA, Lareu RR, Ramsay JP, Peplies J, Reen FJ, Headlam HA, Ward NC, Croft KD, Newsholme P, Hughes JD, O'Gara F.

Microbiome. 2017 Aug 9;5(1):95. doi: 10.1186/s40168-017-0312-4.

13.

Biotechnological Potential of Cold Adapted Pseudoalteromonas spp. Isolated from 'Deep Sea' Sponges.

Borchert E, Knobloch S, Dwyer E, Flynn S, Jackson SA, Jóhannsson R, Marteinsson VT, O'Gara F, Dobson ADW.

Mar Drugs. 2017 Jun 19;15(6). pii: E184. doi: 10.3390/md15060184.

14.

The aliphatic amidase AmiE is involved in regulation of Pseudomonas aeruginosa virulence.

Clamens T, Rosay T, Crépin A, Grandjean T, Kentache T, Hardouin J, Bortolotti P, Neidig A, Mooij M, Hillion M, Vieillard J, Cosette P, Overhage J, O'Gara F, Bouffartigues E, Dufour A, Chevalier S, Guery B, Cornelis P, Feuilloley MG, Lesouhaitier O.

Sci Rep. 2017 Jan 24;7:41178. doi: 10.1038/srep41178.

15.

Harnessing Bacterial Signals for Suppression of Biofilm Formation in the Nosocomial Fungal Pathogen Aspergillus fumigatus.

Reen FJ, Phelan JP, Woods DF, Shanahan R, Cano R, Clarke S, McGlacken GP, O'Gara F.

Front Microbiol. 2016 Dec 22;7:2074. doi: 10.3389/fmicb.2016.02074. eCollection 2016.

16.

The requirements at the C-3 position of alkylquinolones for signalling in Pseudomonas aeruginosa.

Shanahan R, Reen FJ, Cano R, O'Gara F, McGlacken GP.

Org Biomol Chem. 2017 Jan 4;15(2):306-310. doi: 10.1039/c6ob01930g.

PMID:
27901165
17.

Mining Microbial Signals for Enhanced Biodiscovery of Secondary Metabolites.

Reen FJ, Gutiérrez-Barranquero JA, O'Gara F.

Methods Mol Biol. 2017;1539:287-300.

PMID:
27900698
18.

CpxR Activates MexAB-OprM Efflux Pump Expression and Enhances Antibiotic Resistance in Both Laboratory and Clinical nalB-Type Isolates of Pseudomonas aeruginosa.

Tian ZX, Yi XX, Cho A, O'Gara F, Wang YP.

PLoS Pathog. 2016 Oct 13;12(10):e1005932. doi: 10.1371/journal.ppat.1005932. eCollection 2016 Oct.

19.

Synthesis and electrochemical detection of a thiazolyl-indole natural product isolated from the nosocomial pathogen Pseudomonas aeruginosa.

Buzid A, Muimhneacháin EÓ, Reen FJ, Hayes PE, Pardo LM, Shang F, O'Gara F, Sperry J, Luong JH, Glennon JD, McGlacken GP.

Anal Bioanal Chem. 2016 Sep;408(23):6361-7. doi: 10.1007/s00216-016-9749-8. Epub 2016 Jul 29.

PMID:
27473426
20.

Exploiting Interkingdom Interactions for Development of Small-Molecule Inhibitors of Candida albicans Biofilm Formation.

Reen FJ, Phelan JP, Gallagher L, Woods DF, Shanahan RM, Cano R, Ó Muimhneacháin E, McGlacken GP, O'Gara F.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5894-905. doi: 10.1128/AAC.00190-16. Print 2016 Oct.

Supplemental Content

Loading ...
Support Center